BDBM50396426 CHEMBL2170399

SMILES: [#6]-[#6]-[#6]-[#6]-[#7](-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccccc1)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccccc1)-[#6](-[#7])=O)-[#7]-[#6](=O)-[#6@H](-[#6]-c1ccccc1)-[#7]-[#6](=O)-[#6]-[#7]-[#6](=O)-[#6]-[#7]

InChI Key: InChIKey=WUEUJMYZZQSJPB-BBACVFHCSA-N

Data: 1 EC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 50396426   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
GPR103 (Homo sapiens (Human))	BDBM50396426 (CHEMBL2170399) Show SMILES [#6]-[#6]-[#6]-[#6]-[#7](-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccccc1)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccccc1)-[#6](-[#7])=O)-[#7]-[#6](=O)-[#6@H](-[#6]-c1ccccc1)-[#7]-[#6](=O)-[#6]-[#7]-[#6](=O)-[#6]-[#7] |r| Show InChI InChI=1S/C43H60N12O7/c1-2-3-22-55(54-42(62)35(25-31-18-11-6-12-19-31)50-37(57)27-49-36(56)26-44)28-38(58)51-34(24-30-16-9-5-10-17-30)41(61)52-32(20-13-21-48-43(46)47)40(60)53-33(39(45)59)23-29-14-7-4-8-15-29/h4-12,14-19,32-35H,2-3,13,20-28,44H2,1H3,(H2,45,59)(H,49,56)(H,50,57)(H,51,58)(H,52,61)(H,53,60)(H,54,62)(H4,46,47,48)/t32-,33-,34-,35-/m0/s1	UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	2.98E+4	n/a	n/a	n/a	n/a
INSERM Curated by ChEMBL					Assay Description Agonist activity at human GPR103 expressed in CHO cells co-expressing Galpha16 assessed as increase in intracellular calcium level measured for 2 min...				J Med Chem 55: 7516-24 (2012) Article DOI: 10.1021/jm300507d BindingDB Entry DOI: 10.7270/Q2K35VSG
					More data for this Ligand-Target Pair